Chemotherapy-Related Toxicities In Ovarian Cancer Patients
1 other identifier
observational
288
1 country
1
Brief Summary
Primary Objectives:
- To compare preferences of women with ovarian cancer to preferences of their clinical caregivers.
- To compare preferences of women with ovarian cancer to preferences of their familial caregivers.
- To compare preferences of women with ovarian cancer to preferences of a women in the control group.
- To prospectively collect quality of life data from women with ovarian cancer.
- To prospectively collect symptom assessment data from women with ovarian cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2001
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2001
CompletedFirst Submitted
Initial submission to the registry
July 27, 2007
CompletedFirst Posted
Study publicly available on registry
July 30, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 3, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
November 3, 2020
CompletedNovember 13, 2020
November 1, 2020
19.9 years
July 27, 2007
November 11, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Qualitative information on how ovarian cancer patients, their family members, and doctors and nurses feel about the side-effects of chemotherapy.
8 Years
Secondary Outcomes (1)
Patient Response to Quality of Life Using Interview + Questionnaire
30 minute interviews + 15 minutes for questionnaire
Study Arms (1)
Interview & Questionnaires
Interventions
Interview regarding side-effects of chemotherapy, 30-45 minutes.
Quality of life survey and symptom assessment questionnaire, 15 minutes.
Eligibility Criteria
Ovarian cancer patients, their family members, and doctors and nurses from the UTMDACC Gynecologic Oncology Clinic.
You may qualify if:
- Women with epithelial ovarian cancer presenting to the UTMDACC Gynecologic Oncology Clinic who are currently undergoing chemotherapy
- Women with a history of epithelial ovarian cancer presenting to the UTMDACC Gynecologic Oncology Clinic who are seen in follow-up
- Women who are at least 18 years of age
- Women who speak English
- Clinical caregivers of patients with ovarian cancer (UTMDACC gynecologic oncologists, UTMDACC gynecologic medical oncologists, UTMDACC registered nurses and licensed vocational nurses in the UTMDACC Gynecology Clinic, and UTMDACC gynecologic oncology fellows and residents)
- Familial caregivers of patients with ovarian cancer (primary caregiver)
You may not qualify if:
- Participants who are non-English speakers
- Participants who are less than 18 years of age
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Diane C. Bodurka, MD
M.D. Anderson Cancer Center
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 27, 2007
First Posted
July 30, 2007
Study Start
January 1, 2001
Primary Completion
November 3, 2020
Study Completion
November 3, 2020
Last Updated
November 13, 2020
Record last verified: 2020-11